首页> 美国卫生研究院文献>The Journal of Clinical Investigation >The effect of glucocorticoids on thyrotropin secretion
【2h】

The effect of glucocorticoids on thyrotropin secretion

机译:糖皮质激素对促甲状腺激素分泌的影响

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The effect of large doses of glucocorticoids on thyrotropin (TSH) secretion in normal and hypothyroid humans has been studied. Plasma TSH concentrations were measured before, during, and after treatment with dexamethasone given orally for 24-48 hr. In 17 patients with primary hypothyroidism, plasma TSH levels fell significantly during treatment to a mean of 54% of control (range 23-96%). Within 48 hr after the withdrawal of dexamethasone, TSH concentrations transiently increased above pretreatment values. The mean increase was to 156% of control (range 106-294). Similar changes, but of smaller magnitude, were observed in 15 normal subjects. Administration of single oral doses of dexamethasone and oral or intravenous doses of cortisol were followed by reduction of plasma TSH levels to 18-47% of control within 8-12 hr in eight hypothyroid patients. This fall also was followed by significant TSH rises above control values before they returned to the pretreatment levels. Mineralocorticoid administration was not followed by any changes in plasma TSH concentrations in three subjects.TSH responses to steroid were also studied in rats. In hypothyroid rats given dexamethasone intravenously, plasma TSH fell to 63% of control in 30-90 min and then returned to normal or above in 3-4 hr. Dexamethasone also reduced plasma TSH concentrations in normal rats but no rebound was observed in these animals. Dexamethasone did not block the increase in plasma TSH produced by thyrotropin releasing factor (TRF) administration in vivo. Neither basal nor TRF-mediated TSH release from hemipituitaries in vitro was reduced by dexamethasone or corticosterone. These studies indicate that glucocorticoids reduce TSH secretion and suggest that this effect occurs at a suprahypophyseal level.
机译:已经研究了大剂量糖皮质激素对正常人和甲状腺功能低下的人促甲状腺激素(TSH)分泌的影响。在口服地塞米松治疗24、48小时之前,期间和之后测量血浆TSH浓度。在17名原发性甲状腺功能减退症患者中,治疗期间血浆TSH水平显着下降至对照组的54%(23-96%)。撤出地塞米松后48小时内,TSH浓度瞬时升高至高于预处理值。平均增加到对照的156%(范围106-294)。在15名正常受试者中观察到了类似的变化,但幅度较小。在八名甲状腺机能减退患者中,单次口服地塞米松和口服或静脉内注射皮质醇,然后在8-12小时内将血浆TSH水平降低至对照组的18-47%。在下降之前,TSH也显着高于控制值,然后才回到预处理水平。在三名受试者中,盐皮质激素给药后血浆TSH浓度没有任何变化。还在大鼠中研究了TSH对类固醇的反应。在甲状腺功能低下的大鼠中,静脉给予地塞米松,血浆TSH在30-90分钟内降至对照的63%,然后在3-4小时内恢复至正常或更高。地塞米松还降低了正常大鼠的血浆TSH浓度,但在这些动物中未观察到反弹。地塞米松不阻止体内促甲状腺激素释放因子(TRF)给药产生的血浆TSH升高。地塞米松或皮质酮均不能降低体外从半垂体的基础释放或TRF介导的TSH释放。这些研究表明,糖皮质激素可减少TSH分泌,并提示这种作用发生在睑上垂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号